Your Shopping Cart Is Empty
| Report Code: A07075 | Oct 2021 | Pages: 210 | ||
| Tables: 114 | Charts: 53 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Healthcare Interoperability Solutions Market
Request Now !The healthcare interoperability solutions market size was valued at $5,320.0 million in 2020, and is expected to reach $21,544.6 million by 2030, registering a CAGR of 14.9% from 2021 to 2030. Interoperability in healthcare refers to timely and secure access, integration and use of electronic health data so that it can be used to optimize health outcomes for individuals and populations. As populations around the world age and people live longer, interoperability and data sharing are going to become increasingly critical for delivering effective healthcare. Interoperability is the ability of two or more systems to exchange health information and use the information once it is received.
The COVID-19 has affected the market negatively, as the focus has shifted from healthcare interoperability solutions, which are cost-intensive and long term projects, to other IT investments such as patient access management.
The major factors driving the healthcare interoperability solutions market are adoption of cloud technology related to healthcare services. Electronic health record data is increasing rapidly, and therefore, it is difficult to store the bulk data on the local storage devices, as there is chance of losing essential data.
It is difficult to share the bulk amount of data via offline mode. Hence, adoption of healthcare interoperability solutions in the healthcare industry becomes necessary because it allows easy sharing and storage of big data, which in turn drives the healthcare interoperability solutions market around the world. In addition, implementation of various healthcare reforms by the governments has raised the demand for healthcare interoperability solutions in the market. For instance, on June 22, 2020, the U.S. House of Representatives introduced the Patient Protection and Affordable Care Enhancement Act (HR 1425). The bill was designed to strengthen and expand upon the Affordable Care Act (ACA), to curb healthcare expenditure. According to this act, healthcare organizations and physicians have to adopt healthcare interoperability solutions and services to make their operations easier, to improve clinical results and to reduce healthcare costs.
However, increase in concerns regarding the patient data safety & security acts as a restrain to the market. Safeguarding the patient information is a great challenge for healthcare companies, due to increase in cyber-attacks globally. According to the Insurance Information Institute organization, 47% Americans experienced financial identity theft in 2020 and there were 4.8 million identity theft and fraud reports received by the FTC in 2020. Such factors hamper the growth of the market.
The COVID-19 pandemic is an unprecedented global public health challenge and is anticipated to have a positive impact on the healthcare interoperability solutions market for R&D of vaccines and antiviral drugs. Technologies such as interoperability solutions are important in keeping healthcare records. The pandemic has amplified the need of interoperability solutions and services to become realities in the healthcare industry for accurate patient information, linked patient records, interoperability and cyber security continue to be at the forefront of healthcare concerns.
Furthermore, the Asia-Pacific region has a huge market potential for the healthcare interoperability solutions industry. India and China are two rapidly growing economies followed by South Korea, in the Asia-Pacific region. The governments in these countries are making several efforts to cater to the demand for better healthcare services and healthcare infrastructure owing to surge in economies. Hence, it is anticipated that the Asia-Pacific region is expected to create new opportunities during the forecast period.
The healthcare interoperability solutions market is segmented on the basis of level, deployment, end-user and region. By level, the market is segregated into foundational, structural and semantic. On the basis of deployment, the market is divided into cloud-based and on-premise. On the basis of end-user, the market is divided into healthcare providers and healthcare payers. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, South Korea, India, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).
On the basis of level, in 2020, the structural segment dominated the healthcare interoperability solutions market, in terms of revenue, whereas the semantic segment is expected to witness growth at the highest CAGR during the forecast period. On the basis of deployment, in 2020, the cloud-based segment dominated the healthcare interoperability solutions market and is expected to witness growth at the highest CAGR during the forecast period. Depending on end-user, the healthcare providers segment led the market in 2020, in terms of revenue. Whereas, the healthcare payers segment is anticipated to exhibit the highest CAGR in the coming years. Region wise, North America garnered the highest revenue in 2020; however, LAMEA is anticipated to register highest CAGR during the forecast period.
The major players profiled in the healthcare interoperability solutions market include Allscripts Healthcare, LLC, Cerner Corporation, Epic Systems Corporation, Infor, InterSystems Corporation, Jitterbit, Koninklijke Philips N.V., NextGen Healthcare, Inc., Orion Health and ViSolve Inc. Major companies in the market have adopted product launch, business expansion and acquisition as their key developmental strategies to offer better products and services to customers in the healthcare interoperability solutions market.
Key Benefits For Stakeholders
Key Market Segments
By Level
By Deployment
By End-Users
By Region
Key Market Players
Healthcare Interoperability Solutions Market Report Highlights
| Aspects | Details |
|---|---|
| By LEVEL |
|
| By DEPLOYMENT |
|
| By END-USER |
|
| By Region |
|
| Key Market Players | Allscripts Healthcare, LLC, NextGen Healthcare, Inc., InterSystems Corporation, Cerner Corporation, Koninklijke Philips N.V., Orion Health, Infor, ViSolve Inc., Jitterbit, Epic Systems Corporation |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Research methodology
1.2.1.Primary research
1.2.2.Secondary research
1.2.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top impacting factors
3.2.3.Market player positioning
3.3.Key forces shaping healthcare interoperability solutions industry
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Adoption of Cloud technology related to healthcare services
3.4.1.2.Implementation of various healthcare reforms such as Patient Protection and Affordable Care Act (PPACA)
3.4.2.Restraint
3.4.2.1.Increase in concerns regarding the patient data safety & security
3.4.3.Opportunity
3.4.3.1.Increasing investment in the Asia-Pacific region offers huge market potential
3.5.COVID-19 impact analysis
CHAPTER 4:HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL
4.1.Market overview
4.1.1.Market size and forecast, by level
4.2.Foundational
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Structural
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Semantic
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT
5.1.Market overview
5.1.1.Market size and forecast, by deployment
5.2.Cloud-based
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.On-premise
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country
CHAPTER 6:HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER
6.1.Market overview
6.1.1.Market size and forecast, by end-user
6.2.Healthcare providers
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country
6.2.4.Market size and forecast, for healthcare providers, by deployment
6.3.Healthcare payers
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country
CHAPTER 7:HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION
7.1.Market overview
7.1.1.Market size and forecast, by region
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by level
7.2.3.Market size and forecast, by deployment
7.2.4.Market size and forecast, by end-user
7.2.5.Market size and forecast, for healthcare providers, by deployment
7.2.6.Market size and forecast, by country
7.2.6.1.U.S.
7.2.6.1.1.Market size and forecast, by level
7.2.6.1.2.Market size and forecast, by deployment
7.2.6.1.3.Market size and forecast, by end-user
7.2.6.2.Canada
7.2.6.2.1.Market size and forecast, by level
7.2.6.2.2.Market size and forecast, by deployment
7.2.6.2.3.Market size and forecast, by end-user
7.2.6.3.Mexico
7.2.6.3.1.Market size and forecast, by level
7.2.6.3.2.Market size and forecast, by deployment
7.2.6.3.3.Market size and forecast, by end-user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by level
7.3.3.Market size and forecast, by deployment
7.3.4.Market size and forecast, by end-user
7.3.5.Market size and forecast, for healthcare providers, by deployment
7.3.6.Market size and forecast, by country
7.3.6.1.Germany
7.3.6.1.1.Market size and forecast, by level
7.3.6.1.2.Market size and forecast, by deployment
7.3.6.1.3.Market size and forecast, by end-user
7.3.6.2.France
7.3.6.2.1.Market size and forecast, by level
7.3.6.2.2.Market size and forecast, by deployment
7.3.6.2.3.Market size and forecast, by end-user
7.3.6.3.UK
7.3.6.3.1.Market size and forecast, by level
7.3.6.3.2.Market size and forecast, by deployment
7.3.6.3.3.Market size and forecast, by end-user
7.3.6.4.Italy
7.3.6.4.1.Market size and forecast, by level
7.3.6.4.2.Market size and forecast, by deployment
7.3.6.4.3.Market size and forecast, by end-user
7.3.6.5.Rest of Europe
7.3.6.5.1.Market size and forecast, by level
7.3.6.5.2.Market size and forecast, by deployment
7.3.6.5.3.Market size and forecast, by end-user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by level
7.4.3.Market size and forecast, by deployment
7.4.4.Market size and forecast, by end-user
7.4.5.Market size and forecast, for healthcare providers, by deployment
7.4.6.Market size and forecast, by country
7.4.6.1.China
7.4.6.1.1.Market size and forecast, by level
7.4.6.1.2.Market size and forecast, by deployment
7.4.6.1.3.Market size and forecast, by end-user
7.4.6.2.Japan
7.4.6.2.1.Market size and forecast, by level
7.4.6.2.2.Market size and forecast, by deployment
7.4.6.2.3.Market size and forecast, by end-user
7.4.6.3.South Korea
7.4.6.3.1.Market size and forecast, by level
7.4.6.3.2.Market size and forecast, by deployment
7.4.6.3.3.Market size and forecast, by end-user
7.4.6.4.India
7.4.6.4.1.Market size and forecast, by level
7.4.6.4.2.Market size and forecast, by deployment
7.4.6.4.3.Market size and forecast, by end-user
7.4.6.5.Rest of Asia-Pacific
7.4.6.5.1.Market size and forecast, by level
7.4.6.5.2.Market size and forecast, by deployment
7.4.6.5.3.Market size and forecast, by end-user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by level
7.5.3.Market size and forecast, by deployment
7.5.4.Market size and forecast, by end-user
7.5.5.Market size and forecast, for healthcare providers, by deployment
7.5.6.Market size and forecast, by country
7.5.6.1.Latin America
7.5.6.1.1.Market size and forecast, by level
7.5.6.1.2.Market size and forecast, by deployment
7.5.6.1.3.Market size and forecast, by end-user
7.5.6.2.Middle East
7.5.6.2.1.Market size and forecast, by level
7.5.6.2.2.Market size and forecast, by deployment
7.5.6.2.3.Market size and forecast, by end-user
7.5.6.3.Africa
7.5.6.3.1.Market size and forecast, by level
7.5.6.3.2.Market size and forecast, by deployment
7.5.6.3.3.Market size and forecast, by end-user
CHAPTER 8:COMPANY PROFILES
8.1.Allscripts Healthcare, LLC
8.1.1.Company overview
8.1.2.Key executives
8.1.3.Company snapshot
8.1.4.Operating business segments
8.1.5.Product portfolio
8.1.6.R&D Expenditure
8.1.7.Business performance
8.2.Cerner Corporation
8.2.1.Company overview
8.2.2.Key executives
8.2.3.Company snapshot
8.2.4.Operating business segments
8.2.5.Product portfolio
8.2.6.R&D Expenditure
8.2.7.Business performance
8.3.Epic Systems Corporation
8.3.1.Company overview
8.3.2.Key executives
8.3.3.Company snapshot
8.3.4.Product portfolio
8.4.Infor
8.4.1.Company overview
8.4.2.Key executives
8.4.3.Company snapshot
8.4.4.Product portfolio
8.5.InterSystems Corporation
8.5.1.Company overview
8.5.2.Key executives
8.5.3.Company snapshot
8.5.4.Product portfolio
8.6.Jitterbit
8.6.1.Company overview
8.6.2.Key executives
8.6.3.Company snapshot
8.6.4.Product portfolio
8.7.Koninklijke Philips N.V.
8.7.1.Company overview
8.7.2.Key executives
8.7.3.Company snapshot
8.7.4.Operating business segments
8.7.5.Product portfolio
8.7.6.R&D Expenditure
8.7.7.Business performance
8.8.NextGen Healthcare, Inc.
8.8.1.Company overview
8.8.2.Key executives
8.8.3.Company snapshot
8.8.4.Operating business categories
8.8.5.Product portfolio
8.8.6.R&D Expenditure
8.8.7.Business performance
8.9.Orion Health
8.9.1.Company overview
8.9.2.Key executive
8.9.3.Company snapshot
8.9.4.Product portfolio
8.10.ViSolve Inc.
8.10.1.Company overview
8.10.2.Key executives
8.10.3.Company snapshot
8.10.4.Product portfolio
LIST OF TABLES
TABLE 01.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, BY LEVEL, 2020-2030 ($MILLION)
TABLE 02.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR FOUNDATIONAL, BY REGION, 2020-2030 ($MILLION)
TABLE 03.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR STRUCTURAL, BY REGION, 2020-2030 ($MILLION)
TABLE 04.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR SEMANTIC, BY REGION, 2020-2030 ($MILLION)
TABLE 05.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 06.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR CLOUD-BASED, BY REGION, 2020-2030 ($MILLION)
TABLE 07.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR ON-PREMISE, BY REGION, 2020-2030 ($MILLION)
TABLE 08.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, BY END-USER, 2020-2030 ($MILLION)
TABLE 09.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY REGION, 2020-2030 ($MILLION)
TABLE 10.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 11.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR HEALTHCARE PAYERS, BY REGION, 2020-2030 ($MILLION)
TABLE 12.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 13.NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 14.NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 15.NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 16.NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 17.NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 18.U.S. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 19.U.S. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 20.U.S. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 21.CANADA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 22.CANADA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 23.CANADA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 24.MEXICO HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 25.MEXICO HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 26.MEXICO HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 27.EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 28.EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 29.EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 30.EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 31.EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 32.GERMANY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 33.GERMANY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 34.GERMANY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 35.FRANCE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 36.FRANCE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 37.FRANCE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 38.UK HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 39.UK HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 40.UK HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 41.ITALY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 42.ITALY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 43.ITALY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 44.REST OF EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 45.REST OF EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 46.REST OF EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 47.ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 48.ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 49.ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 50.ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 51.ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 52.CHINA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 53.CHINA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 54.CHINA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 55.JAPAN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 56.JAPAN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 57.JAPAN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 58.SOUTH KOREA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 59.SOUTH KOREA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 60.SOUTH KOREA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 61.INDIA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 62.INDIA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 63.INDIA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 64.REST OF ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 65.REST OF ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 67.LAMEA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 68.LAMEA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 69.LAMEA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 70.LAMEA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 71.LAMEA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 72.LATIN AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 73.LATIN AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 74.LATIN AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 75.MIDDLE EAST HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 76.MIDDLE EAST HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 77.MIDDLE EAST HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 78.AFRICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 79.AFRICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 80.AFRICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 81.ALLSCRIPTS HEALTHCARE, LLC: KEY EXECUTIVES
TABLE 82.ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT
TABLE 83.ALLSCRIPTS HEALTHCARE, LLC: OPERATING SEGMENTS
TABLE 84.ALLSCRIPTS HEALTHCARE, LLC: PRODUCT PORTFOLIO
TABLE 85.CERNER CORPORATION: KEY EXECUTIVES
TABLE 86.CERNER CORPORATION: COMPANY SNAPSHOT
TABLE 87.CERNER CORPORATION: OPERATING SEGMENTS
TABLE 88.CERNER CORPORATION: PRODUCT PORTFOLIO
TABLE 89.EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
TABLE 90.EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 91.EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 92.INFOR: KEY EXECUTIVES
TABLE 93.INFOR: COMPANY SNAPSHOT
TABLE 94.INFOR: PRODUCT PORTFOLIO
TABLE 95.INTERSYSTEMS CORPORATION: KEY EXECUTIVES
TABLE 96.INTERSYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 97.INTERSYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 98.JITTERBIT: KEY EXECUTIVES
TABLE 99.JITTERBIT: COMPANY SNAPSHOT
TABLE 100.JITTERBIT: PRODUCT PORTFOLIO
TABLE 101.KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 102.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 103.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 104.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 105.NEXTGEN HEALTHCARE, INC.: KEY EXECUTIVES
TABLE 106.NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT
TABLE 107.NEXTGEN HEALTHCARE, INC.: BUSINESS CATEGORIES
TABLE 108.NEXTGEN HEALTHCARE, INC.: PRODUCT PORTFOLIO
TABLE 109.ORION HEALTH: KEY EXECUTIVE
TABLE 110.ORION HEALTH: COMPANY SNAPSHOT
TABLE 111.ORION HEALTH: PRODUCT PORTFOLIO
TABLE 112.VISOLVE INC.: KEY EXECUTIVES
TABLE 113.VISOLVE INC.: COMPANY SNAPSHOT
TABLE 114.VISOLVE INC.: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.KEY MARKET SEGMENTS
FIGURE 02.GLOBAL HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT, 2020–2030
FIGURE 03.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT, BY COUNTRY, 2020–2030
FIGURE 04.GLOBAL HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: KEY PLAYERS
FIGURE 05.TOP INVESTMENT POCKETS
FIGURE 06.TOP IMPACTING FACTORS
FIGURE 07.MARKET PLAYER POSITIONING
FIGURE 08.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 09.MODERATE-TO-HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE-TO-HIGH THREAT OF SUBSTITUTES
FIGURE 11.MODERATE BARGAINING POWER OF BUYERS
FIGURE 12.MODERATE-TO-HIGH INTENSITY OF RIVALRY
FIGURE 13.MARKET DYNAMICS
FIGURE 14.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR FOUNDATIONAL, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR STRUCTURAL, BY COUNTRY, 2020 & 2030 (%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SEMANTIC, BY COUNTRY, 2020 & 2030 (%)
FIGURE 18.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR CLOUD-BASED, BY COUNTRY, 2020 & 2030 (%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR ON-PREMISE, BY COUNTRY, 2020 & 2030 (%)
FIGURE 21.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 24.HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION, 2020-2030
FIGURE 25.U.S. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 26.CANADA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 27.MEXICO HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 28.GERMANY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 29.FRANCE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 30.UK HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 31.ITALY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 32.REST OF EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 33.CHINA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 34.JAPAN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 35.SOUTH KOREA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 36.INDIA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 37.REST OF ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 38.LATIN AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 39.MIDDLE EAST HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 40.AFRICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 41.ALLSCRIPTS HEALTHCARE, LLC: R&D EXPENDITURE, 2018–2020 ($MILLIONS)
FIGURE 42.ALLSCRIPTS HEALTHCARE, LLC: NET SALES, 2018–2020 ($MILLION)
FIGURE 43.ALLSCRIPTS HEALTHCARE, LLC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 44.ALLSCRIPTS HEALTHCARE, LLC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 45.CERNER CORPORATION: R&D EXPENDITURE, 2018–2020 ($MILLIONS)
FIGURE 46.CERNER CORPORATION: NET SALES, 2018–2020 ($MILLION)
FIGURE 47.CERNER CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 48.KONINKLIJKE PHILIPS N.V.: R&D EXPENDITURE, 2018–2020 ($MILLIONS)
FIGURE 49.KONINKLIJKE PHILIPS N.V.: NET SALES, 2018–2020 ($MILLION)
FIGURE 50.KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 51.KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 52.NEXTGEN HEALTHCARE, INC.: R&D EXPENDITURE, 2018–2020 ($MILLIONS)
FIGURE 53.NEXTGEN HEALTHCARE, INC.: NET SALES, 2018–2020 ($MILLION)
The healthcare interoperability solutions market was valued at $5.3 billion in 2020, and is expected to reach $21.5 billion by 2030, registering a CAGR of 14.9% from 2021 to 2030. The growth of the interoperability solutions market is majorly driven by adoption of cloud technology related to healthcare services. Moreover, implementation of various healthcare reforms and policies by the governments act as a key driving force of the healthcare interoperability solutions market.
However, chances of a cyber-attack on the servers of interoperability solutions can lead to loss of sensitive information and further lead to financial scams, which acts as a major restraint of the healthcare interoperability solutions market. On the contrary, rise in expenditure on healthcare facilities in developing nations such as China, Brazil and India, is expected to create opportunities for growth of the healthcare interoperability solutions market during the forecast period.
Major companies in the market have adopted strategies such as product launch, business expansion and acquisition, to offer better products and services to customers in the healthcare interoperability solutions market.
A. The healthcare interoperability solutions market was valued at $5,320.0 million in 2020, and is expected to reach $21,544.6 million by 2030, registering a CAGR of 14.9% from 2021 to 2030.
A. The forecast period considered for the global healthcare interoperability solutions market is 2021 to 2030, wherein, 2020 is the base year, 2021 is the estimated year, and 2030 is the forecast year.
A. To get latest version of global healthcare interoperability solutions market report can be obtained on demand from the website.
A. The base year considered in the global healthcare interoperability solutions market report is 2020.
A. The top companies holding the market share in the global healthcare interoperability solutions market report include Allscripts Healthcare, LLC, Cerner Corporation, Epic Systems Corporation, Infor, InterSystems Corporation, Jitterbit, Koninklijke Philips N.V., NextGen Healthcare, Inc., Orion Health and ViSolve Inc.
A. The top ten market players are selected based on two key attributes - competitive strength and market positioning
A. By level, the structural segment dominated the global healthcare interoperability solutions market, in terms of revenue and is expected to maintain this trend during the forecast period.
A. By end-Users, the healthcare providers segment is the highest share holder of global healthcare interoperability solutions market.
A. The report contains an exclusive company profile section, where leading 10 companies in the market are profiled. These profiles typically cover company overview, geographical presence, market dominance (in terms of revenue and volume sales), various strategies and recent developments.
A. The market value of the global healthcare interoperability solutions market is $6,197.8 million in 2021.
Start reading instantly.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report